Open AccessLower urinary tract symptoms in patients with advanced prostate cancer: What are the outcomes of androgen deprivation therapy?
Author(s) -
IC Akpayak,
Samaila I Shuaibu,
Chimaobi G. Ofoha,
NK Dakum,
VM Ramyil,
Victor E. Onowa,
Christian A Agbo,
Lemech E. Nabasu,
Zingur Z Galam
Publication year - 2020
Publication title -
nigerian postgraduate medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 19
ISSN - 1117-1936
DOI - 10.4103/npmj.npmj_146_19
Subject(s) - medicine , lower urinary tract symptoms , prostate cancer , androgen deprivation therapy , international prostate symptom score , quality of life (healthcare) , urology , prostate , prospective cohort study , gynecology , cancer , nursing
Androgen deprivation therapy (ADT) is accepted as the first-line treatment of advanced prostate cancer. This study sets out to determine the outcomes of ADT in reducing lower urinary tract symptoms (LUTS) in patients with advanced prostate cancer and also to determine the quality of life (QoL) of the patients.